EPS for MediciNova, Inc. (MNOV) Expected At $-0.09; Legg Mason (LM) Sellers Increased By 11.36% Their Shorts

January 14, 2018 - By Marie Mckinney

Analysts expect MediciNova, Inc. (NASDAQ:MNOV) to report $-0.09 EPS on February, 13.After having $-0.11 EPS previously, MediciNova, Inc.’s analysts see -18.18% EPS growth. The stock increased 1.45% or $0.11 during the last trading session, reaching $7.68. About 36,946 shares traded. MediciNova, Inc. (NASDAQ:MNOV) has declined 6.61% since January 14, 2017 and is downtrending. It has underperformed by 23.31% the S&P500.

Legg Mason Incorporated (NYSE:LM) had an increase of 11.36% in short interest. LM’s SI was 7.37M shares in January as released by FINRA. Its up 11.36% from 6.62M shares previously. With 758,900 avg volume, 10 days are for Legg Mason Incorporated (NYSE:LM)’s short sellers to cover LM’s short positions. The SI to Legg Mason Incorporated’s float is 8.52%. The stock increased 2.15% or $0.92 during the last trading session, reaching $43.74. About 740,174 shares traded. Legg Mason, Inc. (NYSE:LM) has risen 21.07% since January 14, 2017 and is uptrending. It has outperformed by 4.37% the S&P500.

MediciNova, Inc., a biopharmaceutical company, focuses on acquiring and developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company has market cap of $277.25 million. The companyÂ’s product candidate includes MN-166 , an oral anti-inflammatory and neuroprotective agent for the treatment of neurological disorders, including primary and secondary progressive multiple sclerosis; amyotrophic lateral sclerosis; and substance dependence and addiction, including methamphetamine, opioid, and alcohol dependence. It currently has negative earnings. The Company’s product pipeline also comprises MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, such as nonalcoholic steatohepatitis, idiopathic pulmonary fibrosis, and other fibrotic diseases; MN-221 (bedoradrine), a ß2-adrenergic receptor agonist for the treatment of acute exacerbation of asthma; and MN-029 (denibulin), a tubulin binding agent to treat solid tumor cancers.

Investors sentiment increased to 2.67 in 2017 Q3. Its up 1.21, from 1.46 in 2017Q2. It increased, as 2 investors sold MediciNova, Inc. shares while 7 reduced holdings. 4 funds opened positions while 20 raised stakes. 7.88 million shares or 0.85% more from 7.81 million shares in 2017Q2 were reported. 11,259 are owned by Legal & General Gru Public Limited Liability Corporation. Renaissance Techs Ltd Llc invested in 35,600 shares or 0% of the stock. Vanguard Group Inc owns 1.22 million shares. The New York-based Citigroup Incorporated has invested 0% in MediciNova, Inc. (NASDAQ:MNOV). Royal Bank & Trust Of Canada accumulated 2,901 shares. Ny State Common Retirement Fund invested in 19,342 shares. 2.18M were accumulated by Blackrock Inc. Jane Street Ltd Company stated it has 18,600 shares or 0% of all its holdings. Ameritas Inv Partners holds 2,314 shares. Goldman Sachs Gru Inc owns 25,863 shares for 0% of their portfolio. 3,664 are held by Tower Rech Capital Ltd Llc (Trc). Rhumbline Advisers holds 0% of its portfolio in MediciNova, Inc. (NASDAQ:MNOV) for 37,053 shares. Geode Cap Mgmt Lc holds 0% or 226,558 shares in its portfolio. California Pub Employees Retirement Systems holds 42,600 shares. 21,942 are owned by Gp.

Legg Mason, Inc. is a publicly owned asset management holding company. The company has market cap of $3.78 billion. Through its subsidiaries, the firm provides investment management and related services to company-sponsored mutual funds and other investment vehicles including pension funds, foundations, endowments, sovereign wealth funds, insurance companies, private banks, family offices, individuals, as well as to global, institutional, and retail clients. It has a 17.24 P/E ratio. It launches and manages equity, fixed income, and multi-asset customized portfolios through its subsidiaries.

Among 14 analysts covering Legg Mason Inc. (NYSE:LM), 7 have Buy rating, 2 Sell and 5 Hold. Therefore 50% are positive. Legg Mason Inc. had 57 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of Legg Mason, Inc. (NYSE:LM) has “Buy” rating given on Sunday, August 27 by Keefe Bruyette & Woods. RBC Capital Markets maintained Legg Mason, Inc. (NYSE:LM) on Monday, August 3 with “Sector Perform” rating. The firm has “Sector Perform” rating by RBC Capital Markets given on Monday, November 2. The company was maintained on Tuesday, October 10 by Jefferies. On Thursday, August 20 the stock rating was maintained by RBC Capital Markets with “Outperform”. As per Thursday, October 26, the company rating was maintained by Credit Suisse. The firm has “Outperform” rating given on Friday, June 30 by RBC Capital Markets. The firm earned “Overweight” rating on Monday, November 2 by Piper Jaffray. The firm has “Negative” rating given on Thursday, September 3 by Susquehanna. The company was maintained on Wednesday, October 7 by Jefferies.

Investors sentiment decreased to 1.01 in Q3 2017. Its down 0.01, from 1.02 in 2017Q2. It dropped, as 34 investors sold Legg Mason, Inc. shares while 91 reduced holdings. 34 funds opened positions while 92 raised stakes. 74.95 million shares or 1.72% less from 76.26 million shares in 2017Q2 were reported. Clear Harbor Asset Limited Co holds 0.06% or 7,500 shares in its portfolio. Art Advsrs Llc invested in 19,800 shares. Moreover, American Gp has 0.03% invested in Legg Mason, Inc. (NYSE:LM). Loring Wolcott & Coolidge Fiduciary Ltd Liability Partnership Ma reported 27 shares. Credit Suisse Ag stated it has 0% of its portfolio in Legg Mason, Inc. (NYSE:LM). Liberty Mutual Grp Asset Mgmt has 0.05% invested in Legg Mason, Inc. (NYSE:LM). Cornerstone Incorporated has invested 0% in Legg Mason, Inc. (NYSE:LM). Vanguard Group Inc Inc Inc has 0.01% invested in Legg Mason, Inc. (NYSE:LM) for 7.56 million shares. Dalton Greiner Hartman Maher And Com has 511,081 shares. Retail Bank Of Montreal Can has 0% invested in Legg Mason, Inc. (NYSE:LM) for 6,794 shares. Zurcher Kantonalbank (Zurich Cantonalbank) owns 0% invested in Legg Mason, Inc. (NYSE:LM) for 3,193 shares. Asset One Comm Ltd invested in 40,298 shares. State Teachers Retirement System has invested 0.02% of its portfolio in Legg Mason, Inc. (NYSE:LM). Citigroup Inc accumulated 540,053 shares or 0.02% of the stock. Glacier Peak Capital Limited Liability Co owns 10,861 shares for 0.49% of their portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: